Recently, the prostate-specific membrane antigen (PSMA) has been reported to be expressed on the endothelial cells of various solid tumors, including renal cancer, and to enhance angiogenic activity [10,11,12,13,14]. This evidence concerns the gene FOLH1 and renal carcinoma.